Novartis

NOVARTIS NEWSROOM (194 press releases)

Advanced Filtering & Sorting Options:

Patients and R&D Leaders Jointly Present at EU Conference on Progress with Patient-Input to Transform Medicine Development

PRESS RELEASE -- 5, January 2022

(PRESS RELEASE) New York, NY, United States, 5-Jan-2022 — /EuropaWire/ — The Conference Forum announced the launch of the 6th annual EU Patients as Partners in Medicines Development conference to take place virtually on January 24-25th, 2022 GMT time. ​​This … Read the full press release

Paul Bestford to lead Nutreco’s procurement

PRESS RELEASE -- 13, September 2021

(PRESS RELEASE) AMERSFOORT, 13-Sep-2021 — /EuropaWire/ — Nutreco, a global leader in animal nutrition and aquafeed, has announced the appointment of Paul Bestford as the company’s new Chief Procurement Officer (CPO). Paul is coming from Burberry where he led the … Read the full press release

Novartis welcomes new Chief Legal Officer Karen L. Hale

PRESS RELEASE -- 22, March 2021

(PRESS RELEASE) BASEL, 22-Mar-2021 — /EuropaWire/ — Swiss multinational pharmaceutical Novartis appoints Karen L. Hale as Chief Legal Officer. She succeeds Shannon Klinger. Karen will be based in Basel, Switzerland and will join the Executive Committee of Novartis (ECN) and … Read the full press release

Genetic diversity: GSK and Novartis launch Project Africa GRADIENT to optimise treatment responses for malaria and tuberculosis in Africa

PRESS RELEASE -- 19, January 2021

Project Africa GRADIENT calls on local researchers to submit proposals exploring the link between genetic diversity and response to malaria and tuberculosis drugs in African patients. Combined funding commitment of GBP 2.8 million (USD 3.6 million) over five years. Researchers … Read the full press release

Novartis signs 10 year 78 MW renewable Virtual Power Purchase Agreement (VPPA) with Enel Green Power

PRESS RELEASE -- 19, November 2020

The energy will be generated by the 179.9 MW TICO Wind Farm, located in the Spanish province of Zaragoza, Enel Green Power will be a “Green Enabler” for Novartis, supporting the company along its environmental sustainability journey (PRESS RELEASE) ROME, … Read the full press release

Wet Macular Degeneration: Promising data for Novartis’ Beovu unveiled at EURETINA

PRESS RELEASE -- 5, October 2020

In a post-hoc analysis of HAWK and HARRIER, fewer Beovu (brolucizumab) patients had early persistent fluid (12.5% vs. 20.4% of aflibercept patients), defined as the presence of intra-retinal fluid and/or sub-retinal fluid through week 12 of treatment1 Patients with early persistent fluid treated with Beovu experienced greater … Read the full press release

Zurich launches Global Business Platforms unit to expand digital services worldwide

PRESS RELEASE -- 2, September 2020

Zurich accelerates development of digital services, creating a new unit to attract additional customers and meet their rapidly changing needs Jack Howell, CEO Asia Pacific (APAC), to lead the new Global Business Platforms unit focusing on digital services Ericson Chan, … Read the full press release

ChemChina and Sinochem consolidate their agricultural assets to form new holding company, Syngenta Group

PRESS RELEASE -- 6, January 2020

(PRESS RELEASE) BASEL, 6-Jan-2020 — /EuropaWire/ — ChemChina and Sinochem announce the creation of Syngenta Group. The new holding company is the consolidation of both companies’ agricultural assets. Mark Patrick, Chief Financial Officer (CFO) and member of the Syngenta Executive … Read the full press release

Deutsche Bank part of major initiative aimed at creating a common basis for sustainability to be accepted by capital markets

PRESS RELEASE -- 22, August 2019

The initiative aims at transforming the way companies are valued (PRESS RELEASE) FRANKFURT AM MAIN, 22-Aug-2019 — /EuropaWire/ — Deutsche Bank has announced it is joining the value balancing alliance e.V.. Established as a non-profit organization the alliance was founded … Read the full press release

Francesco Balestrieri appointed ad-interim CEO of Sandoz reporting directly to Vas Narasimhan, CEO, Novartis

PRESS RELEASE -- 15, March 2019

(PRESS RELEASE) BASEL, 15-Mar-2019 — /EuropaWire/ — Sandoz’s current Region Head Europe Francesco Balestrieri has just been appointed ad-interim CEO of Sandoz reporting directly to Vas Narasimhan, CEO, Novartis. The change is made as the current CEO of Sandoz, a … Read the full press release

Top Employer’s recognition for SEAT comes as a beacon for attracting external talent

PRESS RELEASE -- 31, January 2019

(PRESS RELEASE) MARTORELL, 31-Jan-2019 — /EuropaWire/ — SEAT’s recognition as a Top Employer in Spain consolidates the company’s commitment to the professional development of its more than 15,000 employees. Top Employer has given the car maker its seal of approval for … Read the full press release

Sandoz certified “TOP Employer Asia Pacific 2019” for its exceptional employee offerings in the region

PRESS RELEASE -- 4, December 2018

Sandoz has been certified by the Top Employers Institute for its exceptional employee offerings in Asia Pacific (APAC) The annual, international research undertaken by the Top Employers Institute recognizes leading employers around the world This exclusive certification underlines Sandoz´ commitment … Read the full press release

Novartis and Pfizer announce clinical development agreement for the treatment of NASH

PRESS RELEASE -- 30, October 2018

Agreement includes a clinical trial to evaluate a combination of tropifexor (LJN452) and one or more Pfizer compounds for the treatment of non-alcoholic steatohepatitis (NASH) Novartis has a leading development portfolio in non-viral liver diseases, including NASH There are currently no … Read the full press release

Philips HealthSuite digital platform selected for the development of Alcon SMART Suite ophthalmology care platform

PRESS RELEASE -- 24, October 2018

Alcon SMART Suite, powered by Philips’ HealthSuite digital platform, aims to drive innovation in ophthalmology delivering personalized and seamless end-to-end care for cataract patients AMSTERDAM, 24-Oct-2018 — /EuropaWire/ — Royal Philips (NYSE: PHG, AEX: PHIA), a global leader in health technology, … Read the full press release

Peter Goldschmidt succeeded Claudio Albrecht as the Chief Executive Officer of STADA Arzneimittel AG

PRESS RELEASE -- 13, September 2018

Goldschmidt: “I look forward to working with the highly experienced team at STADA and continuing the Group’s long-term growth” Supervisory Board Chairman von Au: “Goldschmidt is the right man that STADA needs to ensure the Group successfully retains its strong … Read the full press release

Novartis announces EC approval for Tafinlar® (dabrafenib) in combination with Mekinist® (trametinib) for adjuvant treatment of BRAF V600 mutation-positive melanoma

PRESS RELEASE -- 31, August 2018

Approval based on COMBI-AD study demonstrating greater than 50% reduction in risk of disease recurrence or death in stage III melanoma patients   More than 50% of stage III melanoma patients are likely to recur to stage IV during their lifetime … Read the full press release

Alcon announces an immediate, voluntary market withdrawal of the CyPass Micro-Stent from the global market

PRESS RELEASE -- 31, August 2018

Decision based on five-year data from COMPASS-XT long-term safety study Alcon advises ophthalmic surgeons to cease further implantation BASEL, 31-Aug-2018 — /EuropaWire/ — Reflecting its uncompromising commitment to patient safety, Alcon today announced an immediate, voluntary market withdrawal of the CyPass Micro-Stent from … Read the full press release

Novartis: European Commission approval for Kymriah

PRESS RELEASE -- 30, August 2018

The EC approval is based on the first global CAR-T registration trials, which included patients from eight European countries and demonstrated durable responses and a consistent safety profile in r/r pediatric B-cell ALL and r/rDLBCL Novartis is the only company with an approved … Read the full press release

Novartis: the global Phase III SOLAR-1 trial evaluating the investigational alpha-specific PI3K inhibitor BYL719 has met the primary endpoint

PRESS RELEASE -- 24, August 2018

SOLAR-1 evaluated BYL719 plus fulvestrant vs. fulvestrant alone in HR+/HER2- advanced breast cancer patients with PIK3CA mutations who progressed on or following treatment with an aromatase inhibitor with or without a CDK4/6 inhibitor[1] Approximately 40% of HR+ advanced breast cancer … Read the full press release

Novartis extends agreement with the WHO for the donation of Egaten® for the treatment of liver fluke

PRESS RELEASE -- 25, July 2018

Novartis extends agreement with the WHO for the donation of Egaten® for the treatment of liver fluke, a neglected tropical disease, also known as fascioliasis, that infects more than 2.4 million people globally[1] Since the start of the donation program in … Read the full press release